Facebook-f X-twitter Linkedin-in Instagram Podcast

Podcasts

Episode 27 | NGS panels in lung cancer

In this episode, Dr Malinda Itchins is joined by Professor Stephen Fox, and Professor Michael Millward to discuss NGS panels in lung cancer.

NGS panels in lung cancer

Episode Summary

In this Podcast, Dr Malinda Itchins is joined by Prof Stephen Fox, and Prof Michael Millward to discuss NGS panels in lung cancer. They discuss the logistics and other considerations behind choosing and implementing NGS panels and the potential future application of this technology in clinical management of NSCLC.

Show Hosts

This episode’s host are:

  • Dr Malinda Itchins, Thoracic Medical Oncologist, Royal North Shore Hospital, GenesisCare and North Shore Private
  • Prof Stephen Fox, Head of the Molecular Pathology Library; Director of Pathology, Peter MacCallum Cancer Institute; Professional Fellow, Department of Pathology, University of Melbourne
  • Prof Michael Millward, Medical Oncologist and Cancer Council Professor of Clinical Cancer Research School of Medicine, University of Western Australia

Play Episode 27 | NGS panels in lung cancer

Download Audio File
Listen on Apple
Listen on Spotify

More Podcasts

Headshots of A/Prof Surein Arulananda, A/Prof Mel Moore, Dr. Malinda Itchins. 49 Exploring EGFR Exon 20 Insertion Mutations
49 – Exploring EGFR Exon 20 Insertion Mutations
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
Conversations in Lung Cancer Research - Michael Boyer
48 – A Conversation with Prof. Michael Boyer
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
Text Conversations in Lung Cancer on Blue background and TOGA logo
47 – Introducing Conversations in Lung Cancer Research
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
45 – The Case For IO in Early-Stage NSCLC in a Once in a Lifetime World
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
44 – LCNEC Challenges in Diagnosis and Treatment
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

Facebook-f X-twitter Linkedin-in Instagram Podcast
TOGA
Quicklinks
TOGA is an ACNC Registered Charity

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.

Copyright © 2025 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.